Breaking
4 views

Moderna’s Shift to Cancer Company Lifts Stock Up 177%

Moderna’s Shift to Cancer Company Lifts Stock Up 177%

The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.

The New York Times Verified Source

Syndicated via official news feed

Explore all Breaking stories

Syndicated feed content with full publisher credit.

Breaking Desk

More in Breaking

Continue reading verified coverage and related developments on this desk.

View All

More from Breaking

Latest developments and reports from the desk

All stories →